Central and Peripheral Medication Administration Practices in Pediatric Patients

Author(s): Alicia Sanchez, PharmD, BCPPS, Christopher Campbell, PharmD, BCPPS

Contact Hours 1.00

CERP A 1.00

Pharmacology Hours 1.00

Expires Mar 01, 2027

Topics: Medication Management, Patient Safety

Population: Pediatric

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

Several medication properties should be considered when deciding on central versus peripheral administration, including osmolarity, pH, and concentration. The cumulative risk of phlebitis and the caustic nature of some medications due to these properties will help guide the practitioner, pharmacist, and bedside nurse to determine the ideal prescribing, preparation, and administration techniques to avoid extravasation. Medications that are caustic, high volume or concentration, or a high osmolarity may require central venous catheter administration to avoid burning and to limit the likelihood of extravasation. The purpose of this article is to review complications of central venous catheters, to explain medication properties that should be evaluated when deciding on central or peripheral administration, and to evaluate the literature on peripheral administration of historically centrally administered medications..

Objectives

  • Identify complications of central venous catheters
  • Describe medication properties that should be evaluated when deciding on central or peripheral administration.
  • Assess and analyze medication properties along with primary literature to determine appropriate peripheral or central administration

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.